(Q42041695)

English

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein

scientific article published on April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 October 2017

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein (English)

1 reference

Europe PubMed Central

15 October 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

15 October 2017

5

object named as

Bernard Moss

1 reference

Europe PubMed Central

15 October 2017

Anjeanette Roberts

2

object named as

Anjeanette Roberts

1 reference

Europe PubMed Central

15 October 2017

author name string

Himani Bisht

1

1 reference

Europe PubMed Central

15 October 2017

Leatrice Vogel

3

1 reference

Europe PubMed Central

15 October 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

15 October 2017

1 reference

Europe PubMed Central

15 October 2017

334

1 reference

Europe PubMed Central

15 October 2017

160-165

1 reference

Europe PubMed Central

15 October 2017

2

1 reference

Europe PubMed Central

15 October 2017

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

The Genome sequence of the SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Virology: SARS virus infection of cats and ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

The SARS-CoV S glycoprotein: expression and functional characterization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.042

7 January 2021

Identifiers

10.1016/J.VIROL.2005.01.042

1 reference

Europe PubMed Central

15 October 2017

1 reference

Europe PubMed Central

15 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42041695&oldid=1932459060"